Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice

W. M. Blankesteijn; E. Creemers; E. Lutgens; J. P. Cleutjens; M. J. Daemen; J. F. Smits

doi:https://doi.org/10.1046/j.1365-201X.2001.00887.x

Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice

W. M. Blankesteijn, E. Creemers, E. Lutgens, J. P. Cleutjens, M. J. Daemen, J. F. Smits

Other Departments

Research output: Contribution to journal › Article › Academic › peer-review

102 Citations (Scopus)

Abstract

Recent improvements in the clinical management of acute myocardial infarction (MI) have resulted in a dramatic decrease in mortality because of this condition. This implies that more patients enter the process of infarct healing. This is a highly complex cascade of events which, although studied for decades, is still not completely understood. An increasing number of genetically altered mice can now be studied in a mouse model of MI, to investigate the contribution of the product of the targeted gene to the infarct healing process. In this review, we will discuss the defects in infarct healing that have been observed in null mutants for plasminogen, urokinase-type plasminogen activator (u-PA), matrix metalloproteinases (MMPS), thrombospondin-2 and dishevelled-1. These studies provide new insights in the infarct healing process itself, but may also help to define new diagnostic and therapeutic targets in humans suffering from MI

Original language	English
Pages (from-to)	75-82
Journal	Acta Physiologica Scandinavica
Volume	173
Issue number	1
DOIs	https://doi.org/10.1046/j.1365-201X.2001.00887.x
Publication status	Published - 2001

Access to Document

https://doi.org/10.1046/j.1365-201X.2001.00887.x

Cite this

@article{2d7b13f435fd4acd8bd231aa4bb0a093,

title = "Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice",

abstract = "Recent improvements in the clinical management of acute myocardial infarction (MI) have resulted in a dramatic decrease in mortality because of this condition. This implies that more patients enter the process of infarct healing. This is a highly complex cascade of events which, although studied for decades, is still not completely understood. An increasing number of genetically altered mice can now be studied in a mouse model of MI, to investigate the contribution of the product of the targeted gene to the infarct healing process. In this review, we will discuss the defects in infarct healing that have been observed in null mutants for plasminogen, urokinase-type plasminogen activator (u-PA), matrix metalloproteinases (MMPS), thrombospondin-2 and dishevelled-1. These studies provide new insights in the infarct healing process itself, but may also help to define new diagnostic and therapeutic targets in humans suffering from MI",

author = "Blankesteijn, {W. M.} and E. Creemers and E. Lutgens and Cleutjens, {J. P.} and Daemen, {M. J.} and Smits, {J. F.}",

year = "2001",

doi = "https://doi.org/10.1046/j.1365-201X.2001.00887.x",

language = "English",

volume = "173",

pages = "75--82",

journal = "Acta Physiologica Scandinavica",

issn = "0001-6772",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice

AU - Blankesteijn, W. M.

AU - Creemers, E.

AU - Lutgens, E.

AU - Cleutjens, J. P.

AU - Daemen, M. J.

AU - Smits, J. F.

PY - 2001

Y1 - 2001

N2 - Recent improvements in the clinical management of acute myocardial infarction (MI) have resulted in a dramatic decrease in mortality because of this condition. This implies that more patients enter the process of infarct healing. This is a highly complex cascade of events which, although studied for decades, is still not completely understood. An increasing number of genetically altered mice can now be studied in a mouse model of MI, to investigate the contribution of the product of the targeted gene to the infarct healing process. In this review, we will discuss the defects in infarct healing that have been observed in null mutants for plasminogen, urokinase-type plasminogen activator (u-PA), matrix metalloproteinases (MMPS), thrombospondin-2 and dishevelled-1. These studies provide new insights in the infarct healing process itself, but may also help to define new diagnostic and therapeutic targets in humans suffering from MI

AB - Recent improvements in the clinical management of acute myocardial infarction (MI) have resulted in a dramatic decrease in mortality because of this condition. This implies that more patients enter the process of infarct healing. This is a highly complex cascade of events which, although studied for decades, is still not completely understood. An increasing number of genetically altered mice can now be studied in a mouse model of MI, to investigate the contribution of the product of the targeted gene to the infarct healing process. In this review, we will discuss the defects in infarct healing that have been observed in null mutants for plasminogen, urokinase-type plasminogen activator (u-PA), matrix metalloproteinases (MMPS), thrombospondin-2 and dishevelled-1. These studies provide new insights in the infarct healing process itself, but may also help to define new diagnostic and therapeutic targets in humans suffering from MI

U2 - https://doi.org/10.1046/j.1365-201X.2001.00887.x

DO - https://doi.org/10.1046/j.1365-201X.2001.00887.x

M3 - Article

C2 - 11678729

SN - 0001-6772

VL - 173

SP - 75

EP - 82

JO - Acta Physiologica Scandinavica

JF - Acta Physiologica Scandinavica

IS - 1

ER -